Ophthalmic Medical Product R&D Provider

Producer and Developer of Cosmetic Contact Lenses and Related Technologies
36Kr learned that Eyebright Medical recently stated at an earnings briefing that its controlled subsidiary, Yantai Tianyan Pharmaceutical Technology Co., Ltd., is currently in the capacity ramp-up phase and still has a certain distance from the company's set goals. However, overall, the existing production line operates with relatively high efficiency, and the new production line is being built according to plan. The demand for contact lenses is substantial, and most products in China are still imported. The acquisition of Fujian Unicon will help the company quickly expand its production capacity and reach a leading position in China within a short period. At the same time, the product lines of Tianyan Pharmaceutical and Unicon complement each other, with various certifications and product series providing customers more choices and better supporting market promotion. Currently, both factories are operating at full capacity.Original Link